Newspatrolling.com News cum Content Syndication Portal Online

Breaking News

Oi Wah FY2026 Net Profit Surges by Nearly 48%, Continuous Expansion of Net Interest Margin Demonstrates Business Resilience
Binzhou Unveils “15th Five-Year Plan” Blueprint: A Strategic Focus on Quality Enhancement and Sustainable Development
Gorilla Technology Converts Growth Into Cash: Q1 Revenue Up 55%, Operating Cash Flow Turns Positive & Full Year Guidance Raised
How should pregnant women be cared for and looked after during extreme cold weather?
CGTN: China and Serbia Call for Strengthened Artistic Exchanges and Deeper Friendship

Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

Naman Bansal June 19, 2025 PR

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17^th March, 2025 to 21^st March, 2025.

Check Also

Consistent Infosystems Bags Dual Recognition for Surveillance and Gaming Solutions

~ Recognized as “Trusted Make in India Surveillance Brand” and “Rising Gaming Brand in India” …

toto slot

Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

Related Articles

Check Also